Looking to enter the Chinese market with ease? Freyr offers end-to-end regulatory services in China for pharmaceuticals, medical devices, cosmetics, food supplements, and consumer products. Stay fully compliant with NMPA regulations and get your products market-ready faster.

Learn more: https://www.freyrsolutions.com.cn/

#regulatoryserviceschina #nmpacompliance #marketentrychina

Expand your business in China confidently. Our team provides complete guidance for food supplements registration in China, helping you navigate SAMR regulations and secure smooth, compliant market access.

Learn more: https://www.freyrsolutions.com.cn/food-supplements

#chinaregulations #foodsupplementscompliance #samr

Navigating cosmetic registration in China under NMPA requirements calls for a clear understanding of regulatory documentation, safety standards, and approval pathways. With the right regulatory approach, cosmetic brands can streamline submissions, reduce compliance risks, and stay aligned with China’s evolving cosmetic regulations.

https://www.freyrsolutions.com.....cn/understand-cosme

#nmpacompliance #cosmeticregistrationchina #chinacosmetics

Understanding the medical device approval process in China is critical for successful market entry. Freyr supports manufacturers across device classification, NMPA submissions, and regulatory reviews, helping to align every step with China's medical device regulations. A structured regulatory approach reduces delays and supports confident approvals.

Learn more: https://www.freyrsolutions.com.cn/medical-devices

#medicaldeviceapprovalprocessinchina #nmpa #chinamedicaldevices

Medicinal product registration in China requires a clear regulatory strategy and deep knowledge of NMPA expectations.

Freyr supports companies across classification, CTD dossier preparation, submission, and approval coordination, helping ensure compliance and smoother market entry for medicinal products in China.

Learn more: https://www.freyrsolutions.com.....cn/china-drug-regis

#medicinalproductregistrationchina #nmpa #chinapharmaregulatory